Mar 09, 2017 11:33 am UTC| Business
Dublin, March 09, 2017 -- Research and Markets has announced the addition of the "Spinal Intervention: Markets for Surgical, Replacement and Neurostimulation Technologies" report to their offering. ...
Epizyme Reports 2016 Financial Results and Provides 2017 Pipeline Goals
Mar 09, 2017 11:32 am UTC| Business
Data from Tazemetostat Phase 2 Programs in NHL and Molecularly Defined Solid Tumors Planned for Medical Meetings in Second Quarter Conference Call to Be Held Today at 8:30 a.m. Eastern Time CAMBRIDGE, Mass., March 09,...
Mar 09, 2017 11:30 am UTC| Business
Hyderabad, March 09, 2017 -- The report “Paints And Coating Market -By Type (Architectural/Decorative Coatings, Industrial Special Purpose Coatings) Resin (Alkyd, Epoxy, Acrylic, Polyurethane) Application (Spraying,...
Fairmount Santrol Announces Fourth-Quarter and Full-Year 2016 Results
Mar 09, 2017 11:30 am UTC| Business
FOURTH-QUARTER HIGHLIGHTS Volumes of 2.4 million tons similar to the prior quarter, including Proppant Solutions volumes of 1.8 million tons up 5% sequentiallyRevenues of $140.5 million up 4% sequentially, including...
Mar 09, 2017 11:30 am UTC| Business
CAMBRIDGE, Mass., March 09, 2017 -- Epizyme, Inc. (NASDAQ:EPZM), a clinical-stage biopharmaceutical company creating novel epigenetic therapies, today announced that President of Research and Chief Scientific Officer,...
Vical Reports Fourth Quarter 2016 Financial Results
Mar 09, 2017 11:30 am UTC| Business
SAN DIEGO, March 09, 2017 -- Vical Incorporated (Nasdaq:VICL) today reported financial results for the three and twelve months ended December 31, 2016. Net loss for the fourth quarter of 2016 was $2.8 million, or $0.25...
Mar 09, 2017 11:26 am UTC| Business
Dublin, March 09, 2017 -- Research and Markets has announced the addition of the "Optical Coatings: Technologies and Global Markets" report to their offering. The global market for...